Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) Enterprise Value (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Enterprise Value for 8 consecutive years, with -$7.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 84.42% to -$7.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$7.7 million, a 84.42% increase, with the full-year FY2025 number at -$7.7 million, up 84.42% from a year prior.
  • Enterprise Value was -$7.7 million for Q4 2025 at Select Medical Holdings, up from -$51.4 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $271.4 million in Q2 2025 to a low of -$304.3 million in Q1 2021.
  • A 5-year average of -$76.0 million and a median of -$87.3 million in 2022 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: plummeted 1950.48% in 2021, then skyrocketed 360.89% in 2025.
  • Select Medical Holdings' Enterprise Value stood at -$35.3 million in 2021, then tumbled by 293.23% to -$138.7 million in 2022, then surged by 38.51% to -$85.3 million in 2023, then soared by 41.94% to -$49.5 million in 2024, then surged by 84.42% to -$7.7 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Enterprise Value are -$7.7 million (Q4 2025), -$51.4 million (Q3 2025), and $271.4 million (Q2 2025).